Imagine a future where a cancer drug travels directly to your tumour — guided by magnets, tracked in real time, and activated by gentle heat — without a single incision. That future just got a lot closer.
Researchers at **Michigan State University (MSU)** and **Henry Ford Health**, in collaboration with Arizona State University, have unveiled a new microrobot design called **TriMag** — and it could change the way cancer and brain disease are treated forever.
**Smaller Than a Human Hair**
TriMag microrobots are genuinely tiny. Each device is smaller than a human hair in diameter — fabricated using **3D printing** at a microscopic scale, using biodegradable materials designed to safely break down inside the body after their work is done.
What makes TriMag exceptional is what it packs into that tiny frame: **three integrated magnetic functions**, which is where the name comes from.
- 🧲 **Navigation:** Guided precisely through the body using external magnetic fields — no surgery needed to reach deep-tissue tumours - 🖥️ **Real-Time Imaging:** Tracked via advanced imaging without radiation, giving doctors a clear picture of exactly where the device is - 🔥 **Thermal Therapy:** When it reaches the target, TriMag can be gently heated to destroy tumour cells — a technique called *hyperthermia* — while leaving surrounding healthy tissue intact
Previous microrobot designs could do one or two of these things. TriMag does all three simultaneously in a single device.
**The Problem They Solved**
According to lead researcher **Professor Jinxing Li**, a Red Cedar Distinguished Assistant Professor in MSU's College of Engineering, current microrobots fail inside the human body for a fundamental reason: they can't deliver accurate, real-time, localised images through tissue and organs.
"Now, with advanced microrobotic design and imaging tools, we can reliably build, track and activate microrobots," Li said, describing a system that finally bridges the gap between theoretical promise and real-world clinical potential.
The research findings appear in the journal **Advanced Materials** — one of the most prestigious publications in materials science globally.
**What Conditions Could This Treat?**
The MSU team's vision extends well beyond a single application:
- 🎯 **Cancer treatment** — delivering chemotherapy or thermal energy directly to a tumour, sparing healthy tissue from the systemic side effects of conventional chemo - 🧠 **Brain surgery** — performing precision interventions without the large incisions, long recovery times, and neurological risks of conventional open brain surgery - 👁️ **Eye treatments** — eliminating the need for intraocular injections, which many patients find traumatic - 🩺 **Targeted drug delivery** across a range of hard-to-reach conditions
**Where Are We Now?**
TriMag is currently in **early preclinical testing** — meaning it's being evaluated in lab models before human trials. The pathway from here to hospital use will require years of safety studies, regulatory review, and clinical trials.
But preclinical results are promising, and the elegance of the design — biodegradable, magnetic, multi-functional — addresses the practical barriers that have held back medical microrobotics for years.
**The Bigger Picture**
For cancer patients, the standard of care remains largely systemic: drugs that circulate through the entire body, attacking not just tumours but healthy tissue, causing the well-known ravages of chemotherapy. For brain surgery patients, even "minimally invasive" procedures carry real risks of neurological damage.
TriMag represents a different philosophy: get the treatment *exactly where it needs to go*, and nowhere else.
If it works in humans as researchers hope, it could one day mean the difference between a devastating systemic treatment and a precise, targeted intervention that leaves healthy tissue untouched. 🤖✨
*Sources: MSU Today · Advanced Materials · Michigan State University College of Engineering · Henry Ford Health · March 2026*
